Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Drug Reactions01:27

Allergic Drug Reactions

1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

233
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
233
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

184
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
184
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

245
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
245
Hypersensitivities01:30

Hypersensitivities

8.7K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
8.7K
T Cell Types and Functions01:24

T Cell Types and Functions

3.6K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adiponectin Inhibits AURKA to Suppress Inflammation in TNF-α-induced Keratinocytes and Attenuates Psoriatic Dermatitis in Mice.

Immunity, inflammation and disease·2026
Same author

The roles of dysfunctional attitudes, rumination and mind-wandering in emotional and non-emotional memory of university students in China.

BJPsych open·2026
Same author

Neuromedin B identified as a therapeutic target for atopic dermatitis: evidence from Mendelian randomization and PCR validation.

Frontiers in medicine·2025
Same author

NSSI contagion in adolescent friendships: exploring the impact of peer influence.

Child and adolescent psychiatry and mental health·2025
Same author

Depression and anxiety symptoms associated with internet addiction and non-suicidal self-injury in Chinese adolescent students - a network analysis.

BMC psychiatry·2025
Same author

PTSS, perceived stress, and social media use affecting somatic symptoms in healthcare workers recovering from COVID after ending China's dynamic zero-COVID policy: A moderated mediation model.

Journal of psychiatric research·2025

Related Experiment Video

Updated: Apr 21, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

11.0K

Neuro-immune interactions in urticaria:a pruritus-centric dissection.

Chunxi Ke1, Ni Ma1, Gang Chen2

  • 1Department of Dermatology, The Second Affiliated Hospital of Soochow University, Suzhou, China.

Frontiers in Immunology
|April 20, 2026
PubMed
Summary

Urticaria involves more than histamine; neuroimmune interactions drive persistent itch and inflammation. Targeting these pathways offers new hope for treatment-resistant cases.

Keywords:
itchneuroimmune interactionsneuropeptidetherapeutic targetsurticaria

More Related Videos

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

10.0K
Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
06:43

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses

Published on: March 29, 2017

10.6K

Related Experiment Videos

Last Updated: Apr 21, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

11.0K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

10.0K
Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
06:43

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses

Published on: March 29, 2017

10.6K

Area of Science:

  • Immunology
  • Dermatology
  • Neuroscience

Background:

  • Urticaria is a mast cell-mediated skin condition characterized by itching and wheals.
  • While histamine is key, some patients don't respond well to antihistamines or omalizumab, suggesting other pathways are involved.

Purpose of the Study:

  • To review recent advances in neuroimmune interactions in urticaria.
  • To explore how neuroimmune mechanisms contribute to chronic itch and treatment resistance.
  • To identify potential new therapeutic targets.

Main Methods:

  • Literature review focusing on pruritus (itch) and neuroimmune research in urticaria.
  • Synthesis of current understanding of neuroimmune loops in urticaria pathophysiology.

Main Results:

  • Neuroimmune interactions play a significant role in urticaria, amplifying itch and inflammation.
  • These pathways contribute to mast cell activation, chronicity, and resistance to conventional therapies.
  • Emerging biologics targeting neuroimmune pathways show promise in early trials.

Conclusions:

  • Understanding neuroimmune pathways is crucial for deciphering urticaria pathophysiology.
  • Targeting neuroimmune interactions offers a promising avenue for developing novel, mechanism-based therapies for difficult-to-treat urticaria.